|
Index of reports
> All cases (744)
> Cases with Depression (28)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes all cases where reactions include depression.
Reports 1 - 25 of 28 Next >>
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Depression
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 52 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-09
Patient: 52 year old female, weighing 60.8 kg (133.8 pounds)
Adverse reactions / side effects: Breast Reconstruction, Musculoskeletal Pain, Chemotherapy, Breast Cancer Stage II, Joint Range of Motion Decreased, Vulvovaginal Dryness, Modified Radical Mastectomy, Lymphadenectomy, Depression, Loss of Libido
Suspect drug(s):
Combipatch
Dosage: 50/140 mcg biw, topical
Administration route: Topical
Indication: Menopause
Start date: 2000-07-01
End date: 2001-02-01
Premphase (Premarin;cycrin 14 / 14)
Dosage: 0.625mg
Indication: Menopause
Start date: 1999-03-01
End date: 2000-02-01
Prefest
Dosage: 1-0.9mg
Indication: Menopause
Start date: 2001-05-01
End date: 2003-04-01
Premarin
Dosage: injection nos
Indication: Menstruation Irregular
Start date: 1980-01-01
End date: 1980-01-01
Estring
Dosage: 7.5mg q3mo, topical
Administration route: Topical
Indication: Vulvovaginal Dryness
Start date: 2003-11-01
End date: 2004-10-01
Provera
Dosage: 10mg, qd
Indication: Menopause
Start date: 1986-01-01
Estradiol
Dosage: 1cc-20mg, injection nos
Indication: Menopause
Start date: 1998-01-01
Other drugs received by patient: Synthroid (Levothyroxne Sodium); Wellbutrin; Effexor; Prozac
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-08
Patient: female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Diabetes Mellitus, Pain in Extremity, Hyperhidrosis, Weight Increased, Anxiety, Interstitial Lung Disease, Arthralgia, Alopecia, Systemic Lupus Erythematosus, Trichorrhexis, Depression
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Geritol; Zyrtec
Adverse event in 72 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-17
Patient: 72 year old female, weighing 93.0 kg (204.5 pounds)
Adverse reactions / side effects: Diabetes Mellitus, Pyrexia, Cerebrovascular Disorder, Chronic Obstructive Pulmonary Disease, Macular Degeneration, Cerebral Ischaemia, Colonic Polyp, Glomerulonephritis, Breast Microcalcification, Lymphadenectomy, Breast Cancer, Coronary Angioplasty, Radiotherapy, Breast Mass, Coronary Artery Disease, Tremor, Cholelithiasis, Diverticulum, Arachnoid Cyst, Nervous System Disorder, Cholecystectomy, Adenoma Benign, Spinal Column Stenosis, Refractory Anaemia, Myelodysplastic Syndrome, Dialysis, Cholecystitis, Depression, Acute Myocardial Infarction, Endometrial Disorder, Macrocytosis, Gouty Arthritis, Peripheral Vascular Disorder, Malignant Breast Lump Removal, Cerebrovascular Accident, Renal Failure Chronic, Vascular Graft, Hyperlipidaemia, Anxiety, Osteoarthritis, Peritoneal Dialysis, Hypothyroidism, Hypertension, Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.5 mg, unk
Indication: Menopause
Start date: 1991-01-01
End date: 1996-01-01
Premarin
Administration route: Oral
Indication: Menopause
Start date: 1999-01-01
End date: 2001-01-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1991-01-01
End date: 1999-01-01
Cycrin
Dosage: 5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-01-01
End date: 1999-01-01
MPA
Dosage: 5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-01-01
End date: 2000-01-01
Other drugs received by patient: Celexa; Zestril; Metoprolol Succinate; Lortab; Lipitor; Allopurinol; Synthroid; Ranitidine; Nitroglycerin; Nortriptyline HCL; Norvasc; Cardizem; Capoten; Mevacor; Voltaren; Zaroxolyn
Adverse event in 66 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-10
Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Pyrexia, Macrognathia, Vaginal Disorder, Smear Cervix Abnormal, Mammogram Abnormal, Colonic Polyp, Coeliac Disease, Irritable Bowel Syndrome, Bone Density Decreased, Temperature Intolerance, Cough, Breast Cancer, Pneumonia, Vaginal Discharge, Breast Mass, Cataract Operation, Meniere's Disease, Temporomandibular Joint Syndrome, Vision Blurred, Platelet Count Decreased, Gastric Polyps, Lactose Intolerance, Restless Legs Syndrome, Thrombocythaemia, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Hypokalaemia, Pleural Effusion, Genital Disorder Female, Blood Cholesterol Increased, Depression, Injury, Gastrooesophageal Reflux Disease, Loss of Libido, Cataract, Breast Disorder, Hepatic Enzyme Increased, Anxiety, Mucosal Inflammation, Oral Pain, Epigastric Discomfort, Mastectomy, Hypothyroidism, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Combipatch
Indication: Menopause
Start date: 1991-01-01
Combipatch
Dosage: 0.25 mg, unk
Start date: 2000-01-01
End date: 2000-01-01
Provera
Dosage: 5 mg for 14 days every other month
Indication: Menopause
Start date: 1995-08-01
End date: 1995-09-01
Estraderm
Dosage: 0.05 mg, unk
Indication: Menopause
Start date: 1994-12-01
End date: 2002-01-01
Vivelle
Dosage: 0.05 mg, unk
Indication: Menopause
Aygestin
Ogen
Indication: Menopause
Estratest
Premarin
Prempro
Estrogenic Substance
Oragest
Indication: Menopause
Premarin
Indication: Menopause
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-09
Patient: 65 year old female, weighing 70.7 kg (155.6 pounds)
Adverse reactions / side effects: Confusional State, Biopsy Breast Abnormal, Chemotherapy, Weight Increased, Mammogram Abnormal, Positron Emission Tomogram Abnormal, Hot Flush, Fatigue, Uterine Leiomyoma, Hilar Lymphadenopathy, Depression, Mood Swings, Oestrogen Receptor Assay Positive, Cough, Lung Adenocarcinoma Stage II, Breast Cancer, Metastatic Neoplasm, Self Esteem Decreased, Radiotherapy, Computerised Tomogram Abnormal, Progesterone Receptor Assay Positive, Osteoarthritis, Arthralgia, non-Small Cell Lung Cancer Recurrent, Uterine Dilation and Curettage, Insomnia, Mastectomy, Bronchoscopy Abnormal
Suspect drug(s):
MPA
Indication: Menopausal Symptoms
Start date: 2003-01-23
End date: 2003-10-23
Prempro
Dosage: 0.625/2.5 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1997-06-11
End date: 2002-11-11
Premarin
Dosage: 1.25-6.25 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1988-10-14
End date: 2003-10-20
Provera
Dosage: 10-2.5 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1988-10-14
End date: 1996-03-18
Estraderm
Dosage: .1 mg, unk
Indication: Menopausal Symptoms
Start date: 1992-10-01
End date: 1995-09-01
Premarin
Administration route: Topical
Indication: Menopausal Symptoms
Start date: 2000-08-01
End date: 2002-10-01
Other drugs received by patient: Fluoxetine; Furosemide; Diazepam; Prozac; Valium; Lasix; Effexor
Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-09
Patient: 65 year old female, weighing 70.7 kg (155.6 pounds)
Adverse reactions / side effects: Confusional State, Biopsy Breast Abnormal, Chemotherapy, Weight Increased, Mammogram Abnormal, Positron Emission Tomogram Abnormal, Hot Flush, Fatigue, Uterine Leiomyoma, Hilar Lymphadenopathy, Depression, Mood Swings, Oestrogen Receptor Assay Positive, Cough, Lung Adenocarcinoma Stage II, Breast Cancer, Metastatic Neoplasm, Self Esteem Decreased, Radiotherapy, Computerised Tomogram Abnormal, Progesterone Receptor Assay Positive, Osteoarthritis, Arthralgia, non-Small Cell Lung Cancer Recurrent, Uterine Dilation and Curettage, Insomnia, Mastectomy, Bronchoscopy Abnormal
Suspect drug(s):
MPA
Indication: Menopausal Symptoms
Start date: 2003-01-23
End date: 2003-10-23
Prempro
Dosage: 0.625/2.5 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1997-06-11
End date: 2002-11-11
Premarin
Dosage: 1.25-6.25 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1988-10-14
End date: 2003-10-20
Provera
Dosage: 10-2.5 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1988-10-14
End date: 1996-03-18
Estraderm
Dosage: .1 mg, unk
Indication: Menopausal Symptoms
Start date: 1992-10-01
End date: 1995-09-01
Premarin
Administration route: Topical
Indication: Menopausal Symptoms
Start date: 2000-08-01
End date: 2002-10-01
Other drugs received by patient: Fluoxetine; Furosemide; Diazepam; Prozac; Valium; Lasix; Effexor
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-06-05
Patient: 56 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Hysteroscopy, Liver Disorder, Fibrocystic Breast Disease, Uterine Leiomyoma, Liver Function Test Abnormal, Oedema Peripheral, Breast Microcalcification, Depression, Breast Hyperplasia, Pain in Extremity, Radiotherapy, Malignant Breast Lump Removal, Osteopenia, Hepatic Steatosis, Breast Cancer Metastatic, Uterine Dilation and Curettage, Menometrorrhagia
Suspect drug(s):
Estraderm
Dosage: 0.05mg
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1992-01-01
Premphase 14 / 14
Dosage: 0.625mg
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1999-10-01
Cycrin
Dosage: 10mg unk
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1992-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2002-01-01
Premarin
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-07-01
End date: 1993-01-01
Provera
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1991-12-01
End date: 1996-01-01
Ogen
Indication: Hormone Replacement Therapy
Start date: 1999-01-01
End date: 2002-01-01
Estrace
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 1996-01-01
Prempro
Indication: Menopause
Start date: 2001-12-01
End date: 2002-01-01
Other drugs received by patient: Paxil; Xanax; Pamelor
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-05-22
Patient: 56 year old female, weighing 65.8 kg (144.7 pounds)
Adverse reactions / side effects: Breast Reconstruction, Breast Cancer, Cellulitis, Skin Exfoliation, Radiotherapy, Immunodeficiency, Breast Mass, Erythema, Skin Discolouration, Alopecia, Modified Radical Mastectomy, Tenderness, Depression, Blister, Scar
Adverse event resulted in: hospitalization
Suspect drug(s):
Combipatch
Dosage: .05/.14
Indication: Menopause
Start date: 1999-02-04
End date: 1999-08-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1997-08-15
End date: 1997-12-01
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Menopause
Start date: 1999-09-23
End date: 1999-10-01
Medroxyprogesterone
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Menopause
Start date: 1999-09-23
End date: 2002-04-19
Prempro
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1997-08-15
End date: 1999-01-01
Other drugs received by patient: Wellbutrin; Atenolol; Ranitidine; Zoloft; Nitroglycerin
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-05-22
Patient: 56 year old female
Adverse reactions / side effects: Breast Reconstruction, Lymphadenopathy, Fall, Hot Flush, Depression, Ligament Rupture, Intestinal Polyp, Breast Cancer, Pain in Extremity, Colonoscopy, Osteopenia, Granuloma, Polypectomy, Diverticulum, Keloid Scar, Arthralgia, Radical Mastectomy
Suspect drug(s):
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-01-25
End date: 1995-06-01
Premarin
Dosage: unk, qd
Start date: 1996-01-01
End date: 1999-02-01
Provera
Dosage: 10 mg, unk
Indication: Menopause
Start date: 1994-01-25
End date: 1995-06-01
Provera
Start date: 1996-01-01
End date: 1999-02-01
Estratest H.s.
Indication: Menopause
Start date: 1997-12-01
End date: 1999-02-01
Prempro
Dosage: 0.625/2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1995-06-01
End date: 2002-03-01
Climara
Depo-Estradiol
Dosage: 1 mg, qmo
Indication: Menopause
Combipatch
Dosage: 0.05/0.14 mg/day, unk
Indication: Menopause
Start date: 1999-10-18
End date: 2000-03-14
Adverse event in 57 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-05-10
Patient: 57 year old female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Breast Reconstruction, Lipoma Excision, Breast Disorder, Radiotherapy, Ovarian Cyst, Physical Breast Examination Abnormal, Breast Cancer Stage II, Breast Infection, Fibrocystic Breast Disease, Arthralgia, Electrocardiogram Abnormal, Lipoma, Mastectomy, Breast Microcalcification, Depression
Suspect drug(s):
Estraderm
Dosage: 1 mg, unk
Indication: Menopausal Symptoms
Start date: 1994-01-01
End date: 1994-01-01
Medroxyprogesterone
Dosage: 2.5 mg - 10 mg days 14-25
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-06-14
End date: 1999-07-19
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1992-01-01
End date: 1999-01-01
Estrace
Dosage: 1 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1996-01-01
End date: 1997-01-01
Estradiol
Dosage: 1-2 mg
Administration route: Oral
Indication: Menopause
Start date: 1997-01-01
End date: 1999-10-11
Provera
Dosage: 5 mg, qd
Administration route: Oral
Indication: Menopause
Start date: 1992-01-01
End date: 1999-01-01
Cycrin
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1993-01-01
End date: 1993-01-01
Other drugs received by patient: Prilosec
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-04-27
Patient: female, weighing 49.0 kg (107.9 pounds)
Adverse reactions / side effects: Abdominal Pain, Drug Ineffective, Uterine Polyp, Metastases TO Lymph Nodes, Suicidal Ideation, Weight Increased, Fatigue, Drug Administration Error, Abdominal Distension, Hair Growth Abnormal, Depression, Mood Swings, Oestrogen Receptor Assay Positive, Lymphoedema, Fluid Retention, Breast Pain, Breast Mass, Premenstrual Syndrome, Ill-Defined Disorder, Progesterone Receptor Assay Positive, Carotid Artery Dissection, Metrorrhagia, Breast Cancer Metastatic, Withdrawal Bleeding Irregular, Memory Impairment
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 2003-09-09
Medroxyprogesterone Acetate
Provera
Premarin
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 2003-01-01
Adverse event in 64 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-24
Patient: 64 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Peripheral Coldness, Diverticulitis, Headache, Tricuspid Valve Incompetence, Metastases TO Lymph Nodes, Chemotherapy, Liver Disorder, Nephrolithiasis, Ethmoid Sinus Surgery, Skin Discolouration, Chest Pain, Chronic Sinusitis, Arterial Occlusive Disease, Breast Microcalcification, Depression, Injury, Adrenal Mass, Breast Cancer, Renal Disorder, Anaemia, Breast Mass, Radiotherapy, Sinus Antrostomy, Malignant Breast Lump Removal, Osteopenia, Mitral Valve Sclerosis, Diverticulum, Mastectomy, Breast Fibrosis, Leukopenia
Suspect drug(s):
Estradiol
Dosage: 0.05mg
Indication: Hormone Replacement Therapy
Start date: 2003-02-12
End date: 2003-07-11
Medroxyprogesterone Acetate
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1999-04-09
End date: 2002-12-19
Prempro
Indication: Hormone Replacement Therapy
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2001-03-08
End date: 2002-04-11
Premarin
Dosage: 0.3 mg, qd
Administration route: Oral
Start date: 1994-07-22
End date: 2000-11-06
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2003-01-01
Estraderm
Dosage: 0.05 mg
Indication: Hormone Replacement Therapy
Start date: 2002-12-19
Prometrium
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2003-02-12
End date: 2003-07-19
Cycrin
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 1994-07-22
End date: 1996-02-16
Estrogen NOS
Other drugs received by patient: Novolin 50 / 50; Atenolol; Glucophage; Lariam; Norvasc; Hydrochlorothiazide; Lipitor; Singulair; Avandamet; Albuterol; Prinivil; Plendil; Furosemide; Zestril; Tenex; Cozaar
Adverse event in 58 year old male receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-20
Patient: 58 year old male, weighing 72.6 kg (159.6 pounds)
Adverse reactions / side effects: Night Sweats, Lymphadenopathy, Deafness, Breast Cancer in Situ, Chemotherapy, Hot Flush, Breast Cyst, Uterine Leiomyoma, Posterior Capsulotomy, Maculopathy, Tendonitis, Breast Cancer, Back Pain, Radiotherapy, Breast Mass, Cataract Operation, Diverticulum, Sleep Disorder, Disturbance in Attention, Breast Necrosis, Vitrectomy, Myalgia, Fibrocystic Breast Disease, Uterine Cervical Squamous Metaplasia, Depression, Endometrial Disorder, Scoliosis, Cataract, Musculoskeletal Pain, Breast Dysplasia, Anxiety, Arthralgia, Sexual Dysfunction, Memory Impairment, Spinal Osteoarthritis
Suspect drug(s):
Estraderm
Dosage: 0.05 mg
Indication: Hormone Replacement Therapy
Start date: 1990-08-01
End date: 1990-11-01
MPA
Dosage: 10mg qd
Indication: Hormone Replacement Therapy
Start date: 1990-08-31
End date: 1990-09-01
Premarin
Dosage: .625mg + 0.3mg
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1991-02-01
Estratest H.s.
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1991-03-01
End date: 1996-08-01
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1994-02-01
End date: 1994-08-01
Prempro
Dosage: .625mg/2.5mg
Indication: Hormone Replacement Therapy
Start date: 1994-02-01
End date: 2000-03-01
Prempro
Dosage: 0.625mg/5mg
Provera
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1996-08-01
Android
Dosage: 10
Start date: 1996-12-31
Android
Dosage: 10
Start date: 1997-03-17
Progesterone
Dosage: 10 mg, qd
Start date: 1990-08-31
Other drugs received by patient: Aspirin; Prozac; Ritalin; Adderall 10; Effexor; Levox; Wellbutrin; Zoloft; Serzone; Ginkgo Biloba; Ginseng
Adverse event in 64 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-16
Patient: 64 year old female, weighing 87.1 kg (191.6 pounds)
Adverse reactions / side effects: Radiation Injury, Lens Implant, Pain, Blood Triglycerides Increased, Lipids Increased, Smear Cervix Abnormal, Hypercholesterolaemia, Breast Cyst, Hot Flush, Uterine Leiomyoma, Breast Microcalcification, Depression, Injury, Lymphadenectomy, Application Site Hypersensitivity, Macrocytosis, Endometrial Disorder, Colitis Ischaemic, Cataract, HIP Arthroplasty, Breast Cancer Stage I, Radiotherapy, Cervical Dysplasia, Hypoaesthesia, Malignant Breast Lump Removal, Cataract Operation, Osteoarthritis, Mental Disorder, Feeling Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Combipatch
Dosage: .05/.14 (units unspecified) twice weekly
Indication: Menopause
Start date: 1999-09-26
End date: 2000-11-06
Climara
Dosage: unk, qd
Indication: Menopause
Start date: 2000-10-23
Premarin
Indication: Menopause
Start date: 2000-01-06
Provera
Dosage: 5 mg, qd
Administration route: Oral
Indication: Menopause
Start date: 1995-08-12
End date: 1997-12-08
Provera
Dosage: 2.5 mg, interchanged w/ 5mg based on sx
Provera
Start date: 1993-01-01
End date: 1997-01-01
Premarin
Indication: Menopause
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Dosage: 0.9 mg, qd
Administration route: Oral
Start date: 1995-09-12
End date: 1997-12-07
Premarin
Dosage: 0.3 mg interchanged based on sx
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Estrogen NOS
Indication: Menopause
Prempro
Dosage: unk, qd
Administration route: Oral
Indication: Menopause
Start date: 1996-05-15
Prempro
Dosage: .625/2.5 mg dailoy
Administration route: Oral
Start date: 2000-12-11
End date: 2002-05-07
Other drugs received by patient: Synthroid; Nicoderm
Adverse event in 50 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-16
Patient: 50 year old female, weighing 74.8 kg (164.6 pounds)
Adverse reactions / side effects: Chronic Fatigue Syndrome, Sciatica, Headache, Loss of Consciousness, Vascular Calcification, Hot Flush, Palpitations, Breast Microcalcification, Arteriosclerosis, Muscle Spasms, Breast Pain, Breast Cancer, Back Pain, Pain in Extremity, FAT Necrosis, Osteopenia, Radiculitis Brachial, Pain, Fall, Suicidal Ideation, Fibromyalgia, Intervertebral Disc Disorder, Musculoskeletal Stiffness, Dizziness, Depression, Gastrooesophageal Reflux Disease, Migraine, Dyspnoea, Cervicobrachial Syndrome, Malignant Breast Lump Removal, Arthralgia, Epigastric Discomfort, Spinal Osteoarthritis, Hypertension, Asthenia, Arthritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
Dosage: 0.625mg/2.5mg
Start date: 1998-06-29
End date: 2000-01-01
Prempro
Dosage: ez dial
Start date: 2000-01-03
End date: 2000-04-18
Prempro
Dosage: .625mg/2.5mg
Start date: 2000-04-01
End date: 2001-01-01
Prempro
Dosage: .625mg/5mg
Start date: 2001-02-01
End date: 2002-04-12
Estrogens Conjugated
Dosage: 0.625mg
Administration route: Oral
Start date: 1995-08-07
End date: 1995-08-11
Premarin
Dosage: 0.3mg qd
Indication: Menopause
Provera
Dosage: 10mg
Indication: Menopause
Estraderm
Dosage: 0.05mg unk
Administration route: Topical
Indication: Menopause
Start date: 1993-07-20
Other drugs received by patient: Cartia / USA /; Buspar; Buspar; Nortriptyline HCL; Prozac; Cardizem; Promethazine; Cozaar; Ritalin; Zoloft; Valium; Midrin; Synthroid; Norflex; Desyrel; Klonopin; Compazine; Tylenol W / Codeine NO. 3; Indocin; Lopressor; Pamelor; Protonix; Percocet; Skelaxin; Tamoxifen; Voltaren; Soma; Fioricet; Celebrex; Darvocet-N 100; Fioricet W / Codeine; Levothyroxine Sodium; Adalat - Slow Release; Vicodin
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-16
Patient: 56 year old female, weighing 59.0 kg (129.7 pounds)
Adverse reactions / side effects: Tinnitus, Seroma, Hyperhidrosis, Depression Postoperative, Mammogram Abnormal, Hot Flush, Malaise, Breast Cyst, Uterine Leiomyoma, Bacterial Test Positive, Nervousness, Breast Cancer, Back Pain, Pain in Extremity, Breast Haematoma, Radiotherapy, Libido Decreased, Osteopenia, Bursitis, Dolichocolon, Pain, Breast Oedema, Radiation Skin Injury, Constipation, Gastritis, Abdominal Pain Upper, Weight Increased, Blepharoplasty, Fatigue, Body Dysmorphic Disorder, Nerve Root Lesion, Abdominal Distension, Depression, Oestrogen Receptor Assay Positive, Gastrooesophageal Reflux Disease, Intestinal Polyp, Scoliosis, Haemorrhoids, Deafness Neurosensory, Malignant Breast Lump Removal, Progesterone Receptor Assay Positive, Anxiety, Spinal Osteoarthritis, Asthenia, Hypertension
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Medroxyprogesterone
Dosage: 5 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1998-07-29
End date: 1999-10-01
Estrace
Indication: Hormone Replacement Therapy
Other drugs received by patient: Inderal; Nexium
Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-16
Patient: 58 year old female, weighing 72.6 kg (159.6 pounds)
Adverse reactions / side effects: Atrial Tachycardia, Wheelchair User, Urinary Incontinence, Corneal Disorder, Tricuspid Valve Incompetence, Seroma, Hot Flush, Upper Respiratory Tract Infection, Balance Disorder, Breast Microcalcification, Nodule, Lymphadenectomy, Gallbladder Disorder, Multiple Sclerosis, Muscle Spasms, Breast Cancer, Gastrointestinal Motility Disorder, Dysphagia, Pain in Extremity, Supraventricular Tachycardia, Faecal Incontinence, Breast Mass, Radiotherapy, Osteopenia, Cholelithiasis, Epicondylitis, Spleen Disorder, Cholecystectomy, Muscle Spasticity, Hepatitis, Fall, Myalgia, Diplopia, Speech Disorder, Fatigue, Chest Pain, Blood Cholesterol Increased, Musculoskeletal Stiffness, Cholecystitis, Depression, Gastrooesophageal Reflux Disease, Iridectomy, Neurogenic Bladder, Muscular Weakness, Malignant Breast Lump Removal, Angle Closure Glaucoma, Hepatic Enzyme Increased, Osteoarthritis, Mitral Valve Incompetence, Gait Disturbance
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.1mg
Administration route: Topical
Indication: Hormone Replacement Therapy
Start date: 1992-01-01
End date: 1997-01-01
Provera
Dosage: 10mg unk
Start date: 1984-01-01
End date: 1997-01-01
MPA
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-01-01
Prempro
Dosage: .625mg/2.5mg
Start date: 1998-01-26
End date: 1998-10-21
Prempro
Dosage: .625mg/5mg
Start date: 1998-11-16
End date: 2000-10-19
Premarin
Other drugs received by patient: Prozac; Tamoxifen Citrate; Hydrocodone
Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-04-03
Patient: 65 year old female, weighing 64.9 kg (142.7 pounds)
Adverse reactions / side effects: Diverticulitis, Breast Cellulitis, Exomphalos, Irritable Bowel Syndrome, Depression, Lymphadenectomy, Breast Cancer, Radiotherapy, Malignant Breast Lump Removal, Hernia Repair, Facet Joint Syndrome, Spondylitis, Anxiety, Cholelithiasis, Cholecystectomy, Spinal Osteoarthritis
Suspect drug(s):
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1988-08-08
End date: 1991-01-01
Estrace
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1991-01-01
End date: 1996-01-01
Prempro
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-01-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-01-01
Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-03-30
Patient: 60 year old female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Biopsy Breast Abnormal, Mammogram Abnormal, Hot Flush, Ultrasound Breast Abnormal, Depression, Breast Hyperplasia, Oestrogen Receptor Assay Positive, Menorrhagia, Breast Cancer, Premenstrual Syndrome, Ovarian Cyst, Breast Mass, Meniscus Operation, Progesterone Receptor Assay Positive, Hysterectomy, Meniscus Lesion, Osteoarthritis, Hyperplasia, Adenocarcinoma, Needle Biopsy Site Unspecified Abnormal, Arthroscopy, Salpingo-Oophorectomy Bilateral
Suspect drug(s):
Vivelle-DOT
Dosage: 0.1 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 2000-02-06
End date: 2001-08-27
Estrace
Dosage: 0.1 %, unk
Start date: 1999-07-06
End date: 2001-08-15
Provera
Dosage: 10 mg, ten days of each month
Administration route: Oral
Cycrin
Dosage: unk, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1999-08-04
Cycrin
Dosage: 5 mg, unk
Administration route: Oral
Prempro
Premarin
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1997-01-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Start date: 1999-09-13
Premarin
Dosage: 1.25 mg, unk
Administration route: Oral
Premarin
Dosage: 0.3 mg, unk
Administration route: Oral
End date: 2001-08-15
Estraderm
Dosage: 0.1 mg/day unk
Indication: Hormone Replacement Therapy
Start date: 1999-06-09
End date: 1999-12-10
Vivelle
Dosage: 0.1 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 2000-01-10
Ogen
Indication: Hot Flush
Estrogen NOS
Indication: Hot Flush
Loestrin 1.5 / 30
Dosage: 1/20, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1999-08-16
Aygestin
Dosage: 5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2000-01-10
End date: 2000-03-03
Other drugs received by patient: Rhinocort; Vitamin E; Multi-Vitamins; Vitamin B6; Calcium
Adverse event in 61 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-28
Patient: 61 year old female, weighing 89.8 kg (197.5 pounds)
Adverse reactions / side effects: Breast Cancer, Biopsy Breast Abnormal, Breast Mass, Malignant Breast Lump Removal, Progesterone Receptor Assay Positive, Haemangioma of Liver, Limb Discomfort, Oedema Peripheral, Depression, Lymphadenectomy, Knee Arthroplasty, Oestrogen Receptor Assay Positive, Lung Infiltration
Adverse event resulted in: hospitalization
Suspect drug(s):
Vivelle
Indication: Hormone Replacement Therapy
Vivelle-DOT
Indication: Hormone Replacement Therapy
Estrace
Indication: Night Sweats
Estratab
Dosage: 0.625 mg, qd
Indication: Night Sweats
Estropipate
Dosage: 1 mg, unk
Indication: Amnesia
Prempro
Indication: Amnesia
Premarin
Dosage: 0.625 mg, unk
Indication: Affective Disorder
Provera
Dosage: 2.5 mg, qd
Indication: Hormone Replacement Therapy
Other drugs received by patient: Fish OIL; Alprazolam; Celebrex
Adverse event in 51 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-27
Patient: 51 year old female
Adverse reactions / side effects: Asthma, Facial Palsy, Thrombosis, Lymphadenopathy, Hypoglycaemia, Cerebrovascular Disorder, Lipids Increased, Peripheral Sensory Neuropathy, Uterine Leiomyoma, Irritable Bowel Syndrome, Hypoxia, Postmenopausal Haemorrhage, Breast Cancer, Pneumonia, Pain in Extremity, Breast Mass, Hypoaesthesia, Diverticulum Intestinal, Adenomyosis, Gastric Bypass, Diabetic Neuropathy, Nervous System Disorder, Gastric Polyps, Sleep Apnoea Syndrome, Uterine Haemorrhage, Aphasia, Neuropathy Peripheral, Fibrocystic Breast Disease, Fibromyalgia, Obesity, Depression, Transient Ischaemic Attack, Lymphoedema, Abdominal Pain Lower, Migraine, Motor Dysfunction, Cognitive Disorder, Hysterosalpingo-Oophorectomy, Amnesia, Diabetes Mellitus non-Insulin-Dependent, Cerebrovascular Accident, Anxiety, Dysarthria, Osteoarthritis, Diarrhoea, Arthralgia, Radical Mastectomy, Mastectomy, Gait Disturbance, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-08-01
End date: 2000-02-01
Estraderm
Dosage: 0.5 mg, unk
Start date: 1994-04-01
End date: 1997-06-01
Provera
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-03-01
End date: 1994-08-01
Premarin
Indication: Hormone Replacement Therapy
Vivelle
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1997-10-01
End date: 1997-12-01
MPA
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-09-01
End date: 2000-02-16
Adverse event in 54 year old receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-10
Patient: 54 year old , weighing 90.7 kg (199.5 pounds)
Adverse reactions / side effects: Abdominal Pain, Osteoporosis, X-RAY of Pelvis and HIP Abnormal, Fall, Neuropathy Peripheral, Hot Flush, Psychiatric Symptom, Obesity, Intervertebral Disc Degeneration, Depression, Cushingoid, Breast Cancer, Back Pain, Vomiting, Mass Excision, Osteopenia, Hypoaesthesia, Radicular Pain, Insulin-Requiring Type II Diabetes Mellitus, Diarrhoea, Arthralgia, Dehydration, Mental Disorder, Hypothyroidism, Modified Radical Mastectomy, Hypertension, Chemotherapy Multiple Agents Systemic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 1996-01-01
End date: 2001-01-01
Premarin
Dosage: 0.625 mg, unk
Indication: Menopausal Symptoms
Start date: 1977-01-01
End date: 1996-01-01
Premarin
Other drugs received by patient: Synthroid; Adtz; Prinivil; Cytoxan; Lotrel
Page 1 Next >>
|
